PG
LLY icon

Prostatis Group’s Eli Lilly LLY Stock Holding History

Prostatis Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Buy
539
+120
+29% +$123K 0.15% 101
2026
Q1 		$385K Buy
419
+83
+25% +$84.1K 0.1% 116
2025
Q4 		$361K Sell
336
-42
-11% -$40.2K 0.09% 121
2025
Q3 		$288K Buy
378
+47
+14% +$35K 0.07% 133
2025
Q2 		$258K Sell
331
-12
-3% -$9.32K 0.07% 130
2025
Q1 		$283K Sell
343
-13
-4% -$10.8K 0.09% 125
2024
Q4 		$275K Buy
+356
New +$295K 0.08% 133
2023
Q3 		– Sell
-111
Closed -$52.1K – 178
2023
Q2 		$52.1K Buy
+111
New +$46.5K 0.02% 175

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prostatis Group's LLY Position: Q2 2026 in Review

Prostatis Group increased its Eli Lilly (LLY) stake by 29% in Q2 2026, buying an estimated $123K and bringing the position to 539 shares worth $647K. The position accounts for 0.15% of the portfolio, ranked #101.

Prostatis Group first reported a position in LLY in Q2 2023 and has held it in 8 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Prostatis Group held 539 shares of Eli Lilly worth $647K as of Q2 2026.
  • Prostatis Group bought 120 Eli Lilly shares in Q2 2026, an estimated $123K.
  • Eli Lilly made up 0.15% of Prostatis Group's portfolio in Q2 2026, its #101 holding.
  • Prostatis Group first reported a position in Eli Lilly in Q2 2023 and has held it in 8 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.